» Articles » PMID: 21808043

A Bacterial Process for Selenium Nanosphere Assembly

Overview
Specialty Science
Date 2011 Aug 3
PMID 21808043
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

During selenate respiration by Thauera selenatis, the reduction of selenate results in the formation of intracellular selenium (Se) deposits that are ultimately secreted as Se nanospheres of approximately 150 nm in diameter. We report that the Se nanospheres are associated with a protein of approximately 95 kDa. Subsequent experiments to investigate the expression and secretion profile of this protein have demonstrated that it is up-regulated and secreted in response to increasing selenite concentrations. The protein was purified from Se nanospheres, and peptide fragments from a tryptic digest were used to identify the gene in the draft T. selenatis genome. A matched open reading frame was located, encoding a protein with a calculated mass of 94.5 kDa. N-terminal sequence analysis of the mature protein revealed no cleavable signal peptide, suggesting that the protein is exported directly from the cytoplasm. The protein has been called Se factor A (SefA), and homologues of known function have not been reported previously. The sefA gene was cloned and expressed in Escherichia coli, and the recombinant His-tagged SefA purified. In vivo experiments demonstrate that SefA forms larger (approximately 300 nm) Se nanospheres in E. coli when treated with selenite, and these are retained within the cell. In vitro assays demonstrate that the formation of Se nanospheres upon the reduction of selenite by glutathione are stabilized by the presence of SefA. The role of SefA in selenium nanosphere assembly has potential for exploitation in bionanomaterial fabrication.

Citing Articles

Clinical and mechanistic insights into biomedical application of Se-enriched probiotics and biogenic selenium nanoparticles.

Ataollahi F, Amirheidari B, Amirheidari Z, Ataollahi M Biotechnol Lett. 2025; 47(1):18.

PMID: 39826010 DOI: 10.1007/s10529-024-03559-z.


Biosynthesis of selenium nanoparticles as a potential therapeutic agent in breast cancer: G2/M arrest and apoptosis induction.

Ali B, Allam R, Hasanin M, Hassabo A Toxicol Rep. 2024; 13:101792.

PMID: 39554610 PMC: 11565031. DOI: 10.1016/j.toxrep.2024.101792.


Unveiling the innovative green synthesis mechanism of selenium nanoparticles by exploiting intracellular protein elongation factor Tu from .

Liu P, Long H, He S, Cheng H, Li E, Cheng S J Zhejiang Univ Sci B. 2024; 25(9):789-795.

PMID: 39308068 PMC: 11422800. DOI: 10.1631/jzus.B2300738.


Electroactive Brevundimonas diminuta consortium mediated selenite bioreduction, biogenesis of selenium nanoparticles and bio-electricity generation.

Sakr E, Khater D, El-Khatib K J Nanobiotechnology. 2024; 22(1):352.

PMID: 38902695 PMC: 11188503. DOI: 10.1186/s12951-024-02577-3.


Selenium volatilization in plants, microalgae, and microorganisms.

Wang F, Zhang J, Xu L, Ma A, Zhuang G, Huo S Heliyon. 2024; 10(4):e26023.

PMID: 38390045 PMC: 10881343. DOI: 10.1016/j.heliyon.2024.e26023.


References
1.
Macy J, Rech S, Auling G, Dorsch M, Stackebrandt E, Sly L . Thauera selenatis gen. nov., sp. nov., a member of the beta subclass of Proteobacteria with a novel type of anaerobic respiration. Int J Syst Bacteriol. 1993; 43(1):135-42. DOI: 10.1099/00207713-43-1-135. View

2.
McBroom A, Kuehn M . Release of outer membrane vesicles by Gram-negative bacteria is a novel envelope stress response. Mol Microbiol. 2006; 63(2):545-58. PMC: 1868505. DOI: 10.1111/j.1365-2958.2006.05522.x. View

3.
Stolz J, Oremland R . Bacterial respiration of arsenic and selenium. FEMS Microbiol Rev. 1999; 23(5):615-27. DOI: 10.1111/j.1574-6976.1999.tb00416.x. View

4.
Turner R, Weiner J, Taylor D . Selenium metabolism in Escherichia coli. Biometals. 1998; 11(3):223-7. DOI: 10.1023/a:1009290213301. View

5.
Pugsley A . The complete general secretory pathway in gram-negative bacteria. Microbiol Rev. 1993; 57(1):50-108. PMC: 372901. DOI: 10.1128/mr.57.1.50-108.1993. View